{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:40:37Z","timestamp":1760301637742,"version":"build-2065373602"},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T00:00:00Z","timestamp":1278979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cytopathology"],"published-print":{"date-parts":[[2010,10,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines for the management of women with abnormal cervical screening test results is a powerful, evidence\u2010based document representing an advance in the consistent treatment of women with cervical abnormalities. Nevertheless, the complexity of the guidelines is an outstanding issue, compliance with the guidelines is problematic in some areas, and there is a growing recognition of the deficiencies of colposcopy. In light of these challenges, the cytopathology community has an opportunity to play an active role in integrating data, defining risk, and recommending proper management for women screened for cervical cancer. Cancer (Cancer Cytopathol) 2010. \u00a9 2010 American Cancer Society.<\/jats:p>","DOI":"10.1002\/cncy.20097","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T10:54:29Z","timestamp":1279018469000},"page":"233-237","source":"Crossref","is-referenced-by-count":4,"title":["The 2006 consensus guidelines for the management of women with abnormal cervical screening tests"],"prefix":"10.1002","volume":"118","author":[{"given":"Terence J.","family":"Colgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,13]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_3_2_2","DOI":"10.1001\/jama.287.16.2120"},{"doi-asserted-by":"publisher","key":"e_1_2_3_3_2","DOI":"10.1097\/LGT.0b013e3181585870"},{"doi-asserted-by":"publisher","key":"e_1_2_3_4_2","DOI":"10.1097\/LGT.0b013e318159408b"},{"doi-asserted-by":"publisher","key":"e_1_2_3_5_2","DOI":"10.1097\/01.AOG.0000159549.56601.75"},{"doi-asserted-by":"publisher","key":"e_1_2_3_6_2","DOI":"10.1016\/j.ypmed.2005.09.010"},{"doi-asserted-by":"publisher","key":"e_1_2_3_7_2","DOI":"10.1007\/978-1-4612-2042-8_3"},{"doi-asserted-by":"publisher","key":"e_1_2_3_8_2","DOI":"10.1016\/j.ygyno.2007.01.040"},{"doi-asserted-by":"publisher","key":"e_1_2_3_9_2","DOI":"10.1097\/01.lgt.0000210130.01016.ad"},{"doi-asserted-by":"publisher","key":"e_1_2_3_10_2","DOI":"10.1016\/S1701-2163(16)30136-0"},{"unstructured":"SharplessK RobinsonC SchnatzP.Adherence to practice guidelines for women with atypical glandular cells on cervical cytology: a follow\u2010up analysis. Paper presented at: The American Society for Colposcopy and Cervical Pathology (ASCCP) Biennial Meeting; March 24\u201027 2010; Las Vegas Nevada.","key":"e_1_2_3_11_2"},{"key":"e_1_2_3_12_2","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.5858\/2008-132-1290-HPTARR","article-title":"Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006","volume":"132","author":"Moriarty AT","year":"2008","journal-title":"Arch Pathol Lab Med."},{"unstructured":"LeeJW BerkowitzZ SaraiyaM.Low\u2010risk human papillomavirus testing among U.S. Pap test providers 2006. Paper presented at: The American Society for Colposcopy and Cervical Pathology (ASCCP) Biennial Meeting; March 24\u201027 2010; Las Vegas Nevada.","key":"e_1_2_3_13_2"},{"unstructured":"ButlerSL WilkinsonEJ.Profiles of oncogenic HPV ordering: ASCCP\/ACS guideline vs non\u2010guideline compliance. Paper presented at: The American Society for Colposcopy and Cervical Pathology (ASCCP) Biennial Meeting; March 24\u201027 2010; Las Vegas Nevada.","key":"e_1_2_3_14_2"},{"key":"e_1_2_3_15_2","first-page":"232A","article-title":"HPV DNA testing: is it used appropriately?","volume":"23","author":"Davion S","year":"2010","journal-title":"Mod Pathol."},{"doi-asserted-by":"publisher","key":"e_1_2_3_16_2","DOI":"10.1016\/j.ajog.2006.01.091"},{"doi-asserted-by":"publisher","key":"e_1_2_3_17_2","DOI":"10.1097\/LGT.0b013e3181a4e497"},{"unstructured":"American Society for Colposcopy and Cervical Pathology. Descriptions of new FDA\u2010approved HPV DNA tests. Available at:http:\/\/www.asccp.org\/pdfs\/consensus\/clinical_update_20090408.pdf. Accessed March 31 2010.","key":"e_1_2_3_18_2"},{"key":"e_1_2_3_19_2","first-page":"372","article-title":"Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low\u2010grade squamous intraepithelial lesion triage study: implications for subject safety and lead\u2010time bias","volume":"12","author":"Sherman ME","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"unstructured":"SellorsJW QiaoY BaoY et al.False\u2010negative colposcopy: quantifying the problem. Paper presented at: 22nd International HPV Conference and Clinical Workshop; April 30\u2010May 6 2005; Vancouver British Columbia Canada.","key":"e_1_2_3_20_2"},{"doi-asserted-by":"publisher","key":"e_1_2_3_21_2","DOI":"10.1016\/j.ajog.2004.02.065"},{"unstructured":"PretoriusR BelinsonJ BurchetteR HuS QiaoY.Regardless of skill performing more biopsies improves colposcopic accuracy. Paper presented at: The American Society for Colposcopy and Cervical Pathology (ASCCP) Biennial Meeting; March 24\u201027 2010; Las Vegas Nevada.","key":"e_1_2_3_22_2"},{"unstructured":"NamK ChungS KimJ JeonS ChoY BaeD.Are random biopsies in addition to colposcopy directed biopsy necessary in the diagnosis of cervical intraepithelial neoplasia (CIN) II or worse?Paper presented at: The American Society for Colposcopy and Cervical Pathology (ASCCP) Biennial Meeting; March 24\u201027 2010 Las Vegas Nevada.","key":"e_1_2_3_23_2"},{"doi-asserted-by":"publisher","key":"e_1_2_3_24_2","DOI":"10.1016\/j.ygyno.2009.09.001"},{"doi-asserted-by":"publisher","key":"e_1_2_3_25_2","DOI":"10.1097\/01.AOG.0000220505.18525.85"},{"doi-asserted-by":"publisher","key":"e_1_2_3_26_2","DOI":"10.1016\/j.ajog.2007.07.049"},{"key":"e_1_2_3_27_2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.5858\/134.5.744","article-title":"The Pittsburgh Cervical Cancer Screening Model. A risk assessment tool","volume":"134","author":"Austin R","year":"2010","journal-title":"Arch Pathol Lab Med."}],"container-title":["Cancer Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncy.20097","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncy.20097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:00:41Z","timestamp":1760299241000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncy.20097"}},"subtitle":["Challenges remain"],"short-title":[],"issued":{"date-parts":[[2010,7,13]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10,25]]}},"alternative-id":["10.1002\/cncy.20097"],"URL":"https:\/\/doi.org\/10.1002\/cncy.20097","archive":["Portico"],"relation":{},"ISSN":["1934-662X","1934-6638"],"issn-type":[{"type":"print","value":"1934-662X"},{"type":"electronic","value":"1934-6638"}],"subject":[],"published":{"date-parts":[[2010,7,13]]}}}